Author | Timothy N. Troy

Articles

Limited TIMs?

September 01, 2003

London -- A report published by Britain's National Prescribing Center saying that Fujisawa's Protopic (tacrolimus) and Novartis' Elidel (pimecrolimus) have only a limited role in the treatment of eczema was intended for general practitioners rather than dermatologists and refers mostly to mild cases treated in primary care settings.

Botox battles heat up

January 01, 2003

Palm Beach, Fla. - Dermatologists apparently have had enough hype, spam, and promotion of new retail creams claiming to be "better" than mainstay anti-aging products. The upshot is a first-ever clinical comparison of such topicals to botulinum toxin A, a wrinkle fighter turned household word by Allergan's Botox Cosmetic.

Professor claims diet does, after all, affect acne

January 01, 2003

A report from a University of Colorado professor has dermatologists scratching their heads and pondering more than 30 years of medical teaching and patient advice. Does diet, or more specifically the wrong diet, lead to the sebaceous secretions that cause acne vulgaris?

Smallpox Vaccine: a Derm Dilemma

January 01, 2003

President George W. Bush's announcement of a tiered national vaccination program for smallpox drew a quick response from the American Academy of Dermatology and prompted a fundamental debate: Should dermatologists receive the vaccine?